All Stories
Follow
Subscribe to Eckert & Ziegler Strahlen und Medizintechnik AG

Eckert & Ziegler Strahlen und Medizintechnik AG

ots Ad hoc-Service: Eckert & Ziegler AG <DE0005659700> Eckert & Ziegler Doubles its Nine Month Revenues

Berlin (ots Ad hoc-Service) -

Ad hoc-announcement edited and sent by DGAP. The sender is solely
responsible for the contents of this announcement.
Eckert & Ziegler AG, a specialist for the provision of
miniaturized, low-level radiation sources for the treatment of cancer
and cardiovascular diseases continued its expansion in the third
quarter of 2000. The company increased its revenues by 124% to 15.9
Mio EUR (7.1 Mio EUR) compared with the prior year period. Results
from ordinary activities climbed by 287% to 2.1 Mio EUR (0.6 Mio
EUR). Cash flow rose by 153% to 4.6 Mio EUR (1.8 Mio EUR).
Encouragingly enough, all segments contributed to driving this
sales growth with the 400% increase marked up by Oncology standing
out by comparison with the previous year. The other product areas,
Cardiology, Medical Reference Sources and Science and Industry, were
each able to approximately double their sales. The quarter is the
sixth consecutive quarter in which revenue have more then doubled in
comparison to the previous year.
The management team is confident that it will substantially exceed
the 2000 revenue target of 19.1 Mio EUR that was announced earlier
this year. It also expects to reach the after-tax results of 2.1 Mio
EUR, since there will be a number of milestone payments related to
project completions.
The Board of Directors
For further information please contact: Karolin Riehle Investor
Relations Eckert & Ziegler AG Robert-Rössle Str. 10 13125 Berlin
Tel.: (+49 30) 94 10 84-138 Fax: (+49 30) 94 10 84-220
End
Internet: http://recherche.newsaktuell.de

Original content of: Eckert & Ziegler Strahlen und Medizintechnik AG, transmitted by news aktuell

More stories: Eckert & Ziegler Strahlen und Medizintechnik AG
More stories: Eckert & Ziegler Strahlen und Medizintechnik AG